These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 183261)

  • 21. Combination chemotherapy with CCNU, vincristine and methotrexate in primary and metastatic brain tumors.
    Hildebrand J; Brihaye J; Wagenknecht L; Michel J; Kenis Y
    Eur J Cancer (1965); 1975 Aug; 11(8):585-7. PubMed ID: 1222765
    [No Abstract]   [Full Text] [Related]  

  • 22. CCNU in brain tumours.
    Garrett MJ; Hughes HJ; Ryall RD
    Clin Radiol; 1975 Apr; 26(2):183-4. PubMed ID: 1149380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nitrosoureas in central nervous system tumors.
    Walker MD
    Cancer Chemother Rep 3; 1973 May; 4(3):21-6. PubMed ID: 4584033
    [No Abstract]   [Full Text] [Related]  

  • 24. [Chemotherapy of brain neoplasms in children].
    Jacobi H
    Z Allgemeinmed; 1974 Sep; 50(25):1092-6. PubMed ID: 4373943
    [No Abstract]   [Full Text] [Related]  

  • 25. The nitrosoureas: carmustine (BCNU) and lomustine (CCNU).
    Weiss RB; Issell BF
    Cancer Treat Rev; 1982 Dec; 9(4):313-30. PubMed ID: 6762924
    [No Abstract]   [Full Text] [Related]  

  • 26. Predicting and monitoring response to chemotherapy by 1,3-bis(2-chloroethyl)-1-nitrosourea in subcutaneously implanted 9L glioma using the apparent diffusion coefficient of water and 23Na MRI.
    Babsky AM; Hekmatyar SK; Zhang H; Solomon JL; Bansal N
    J Magn Reson Imaging; 2006 Jul; 24(1):132-9. PubMed ID: 16758478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative DNA analysis of an intracerebrally transplanted brain tumour model after experimental chemotherapy with BCNU and CCNU.
    Schlegel J; Stumm G; Ruschoff J; Mennel HD
    Exp Toxicol Pathol; 1995 Sep; 47(4):313-8. PubMed ID: 8855128
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adjuvant nitrosourea therapy for glioblastoma.
    Brisman R; Housepian EM; Chang C; Duffy P; Balis E
    Arch Neurol; 1976 Nov; 33(11):745-50. PubMed ID: 985152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Use of nitrosourea derivatives in the treatment of patients with Hodgkin's disease with lesions of the central nervous system].
    Gershanovich ML; Arkhipov AI; Vilenskiĭ BS
    Vopr Onkol; 1988; 34(5):542-9. PubMed ID: 3381494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of mycosis fungoides with topical nitrosourea compounds: Further studies.
    Zackheim HS; Epstein EH
    Arch Dermatol; 1975 Dec; 111(12):1564-70. PubMed ID: 1200661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination chemotherapy of malignant glioma. Effect of postoperative treatment with CCNU, vincristine, amethopterine and procarbazine.
    Heiss WD; Turnheim M; Mamoli B
    Eur J Cancer (1965); 1978 Nov; 14(11):1191-202. PubMed ID: 216554
    [No Abstract]   [Full Text] [Related]  

  • 32. Activity of fotemustine in medulloblastoma and malignant glioma xenografts in relation to O6-alkylguanine-DNA alkyltransferase and alkylpurine-DNA N-glycosylase activity.
    Vassal G; Boland I; Terrier-Lacombe MJ; Watson AJ; Margison GP; Vénuat AM; Morizet J; Parker F; Lacroix C; Lellouch-Tubiana A; Pierre-Kahn A; Poullain MG; Gouyette A
    Clin Cancer Res; 1998 Feb; 4(2):463-8. PubMed ID: 9516937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [On the therapy of lymphogranuloma. CCNU (1(2-chlorethyl)-3-cyclohexyl-1-nitrosourea) and BCNU (1,3-bis(2-chlorethyl)-1-nitrosourea) as well as BCNU combinations in Hodgkin's lymphogranuloma, stage 3 and 4].
    Brunner KW; Maurice P; Sonntag RW
    Schweiz Med Wochenschr; 1972 Oct; 102(43):1546-51. PubMed ID: 4647016
    [No Abstract]   [Full Text] [Related]  

  • 34. Chemotherapy: the agents in current use.
    Levin VA; Wilson CB
    Semin Oncol; 1975 Mar; 2(1):63-7. PubMed ID: 795035
    [No Abstract]   [Full Text] [Related]  

  • 35. The effect of phenobarbital pretreatment on the antitumor activity of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl-1-nitrosourea (PCNU), and on the plasma pharmacokinetics and biotransformation of BCNU.
    Levin VA; Stearns J; Byrd A; Finn A; Weinkam RJ
    J Pharmacol Exp Ther; 1979 Jan; 208(1):1-6. PubMed ID: 759602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Use of nitrosourea compounds in cancer chemotherapy].
    Robak T
    Pol Tyg Lek; 1982 Sep; 37(36):1067-70. PubMed ID: 6763214
    [No Abstract]   [Full Text] [Related]  

  • 37. Nitrosoureas in multiple myeloma.
    Salmon SE
    Cancer Treat Rep; 1976 Jun; 60(6):789-94. PubMed ID: 782701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-dose chemotherapy with autologous stem cell transplantation in adults with recurrent embryonal tumors of the central nervous system.
    Gill P; Litzow M; Buckner J; Arndt C; Moynihan T; Christianson T; Ansell S; Galanis E
    Cancer; 2008 Apr; 112(8):1805-11. PubMed ID: 18300237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemotherapy of primary malignant brain tumors in children.
    Shapiro WR
    Cancer; 1975 Mar; 35(3 suppl):965-72. PubMed ID: 1111955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Value of chemotherapy associated with conventional treatment of malignant gliomas of the brain. Study of 95 cases with histological verification and follow-up of 1 to 6 years 9 months].
    Paillas JE; Prince MA; Hassoun J; Pellet W; Peragut JC
    Rev Neurol (Paris); 1979 Mar; 135(3):251-62. PubMed ID: 227020
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.